ARYMX | MGLRX | ARYMX / MGLRX | |
Total Expense Ratio | 1.37 | 0.85 | 161% |
Annual Report Gross Expense Ratio | 1.37 | 0.86 | 159% |
Fund Existence | 14 years | 13 years | - |
Gain YTD | 6.899 | 5.784 | 119% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 856M | 2.23B | 38% |
Annual Yield % from dividends | 1.78 | 2.55 | 70% |
Returns for 1 year | -0.20 | -4.93 | 4% |
Returns for 3 years | 19.78 | 1.67 | 1,186% |
Returns for 5 years | 25.75 | 12.07 | 213% |
Returns for 10 years | 60.56 | 43.70 | 139% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WHGOX | 12.62 | -0.03 | -0.24% |
Westwood Income Opportunity Ultra | |||
PMVEX | 26.73 | -0.23 | -0.85% |
PGIM Quant Solutions Mid-Cap Val R2 | |||
FIICX | 18.61 | -0.17 | -0.91% |
Fidelity Advisor Mid Cap II C | |||
JMEEX | 67.73 | -0.65 | -0.95% |
JPMorgan Mid Cap Equity R5 | |||
LHCSX | 19.55 | -0.25 | -1.26% |
Lord Abbett Health Care R4 |